Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Central Sleep Apnea (CSA)

Central Sleep Apnea and Sleep Related Hypoventilation/Hypoxemic Syndromes

Central sleep apnea (CSA) and sleep related hypoventilation/hypoxemic syndromes are sleep related respiratory conditions. 

CSA occurs when you repeatedly stop breathing during sleep because your brain does not cue your body to breathe. This differs from obstructive sleep apnea since in central sleep apnea, there is no breathing effort because there is no drive to breathe. In its primary form, CSA is the result of instability of the breathing control system as the individual transitions from wakefulness to sleep. 

Sleep related hypoventilation/hypoxemic syndromes may be the result of a decreased response to low oxygen or high carbon dioxide during wakefulness and sleep and are characterized by frequent episodes of shallow breathing lasting longer than 10 seconds during sleep.

Condition Spotlight

Image of upchurch-sleep-apnea-1.jpg
After Years of Exhaustion, Aircraft Mechanic Now Wakes Up Rested

Clinical Trials for Central Sleep Apnea (CSA)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Closed Trials